Income Taxes	6 Months Ended
Jul. 02, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income tax expense was $1.5 million and $0.8 million (with effective tax rates of 7.6% and 8.1%) for the second quarter of 2017 and 2016, respectively, and $4.2 million and $3.5 million (with effective tax rates of 12.2% and 14.8%) for June year to date 2017 and 2016, respectively. Our tax expense is affected by recurring items, such as the amount of pretax income and its mix by jurisdiction, U.S. work opportunity credits and the change in cash surrender value of non-taxable investments in life insurance policies. It is also affected by discrete items that may occur in any given period but are not consistent from period to period, such as tax law changes, or changes in judgment regarding the realizability of deferred tax assets. Income tax expense in the second quarter of 2017 benefited from the release of a valuation allowance in Norway and from increases in the cash surrender value of life insurance policies. There could be an income tax benefit from a valuation allowance release of approximately $5 million in the near term if future taxable income is sufficient to make it more likely than not that deferred tax assets will be realizable in certain jurisdictions.

Income Taxes

6 Months Ended

Jul. 02, 2017

Income tax expense was $1.5 million and $0.8 million (with effective tax rates of 7.6% and 8.1%) for the second quarter of 2017 and 2016, respectively, and $4.2 million and $3.5 million (with effective tax rates of 12.2% and 14.8%) for June year to date 2017 and 2016, respectively. Our tax expense is affected by recurring items, such as the amount of pretax income and its mix by jurisdiction, U.S. work opportunity credits and the change in cash surrender value of non-taxable investments in life insurance policies. It is also affected by discrete items that may occur in any given period but are not consistent from period to period, such as tax law changes, or changes in judgment regarding the realizability of deferred tax assets. Income tax expense in the second quarter of 2017 benefited from the release of a valuation allowance in Norway and from increases in the cash surrender value of life insurance policies. There could be an income tax benefit from a valuation allowance release of approximately $5 million in the near term if future taxable income is sufficient to make it more likely than not that deferred tax assets will be realizable in certain jurisdictions.